iRadimed (IRMD)
(Delayed Data from NSDQ)
$44.40 USD
-1.75 (-3.79%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $44.26 -0.14 (-0.32%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum C VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 40% (101 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.57 | 9.99 |
Current Quarter Estimate | 0.38 | 3.93 | 61.00 |
Year Ago Quarter Estimate | 0.43 | 3.85 | 54.84 |
Next Quarter Estimate | 0.43 | 3.92 | 63.00 |
Next Year Estimate | 1.75 | 19.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.05 | 11.50 | 15.67 |
Next Year | 13.64 | 22.00 | 11.34 |
Last 5 Years | 25.30 | 10.20 | 8.10 |
Next 5 Years | NA | 14.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 27.75 | 29.13 |
Price/Book (MRQ) | 7.06 | 2.41 |
Price/Cash Flow (MRFY) | 31.18 | 17.64 |
Dividend Yield | 1.35% | 0.00% |
Net Profit Margin (TTM) | 26.83% | 9.39% |
Return on Equity (TTM) | 24.71% | 13.04% |
Debt to Equity (MRQ) | 0.00 | 34.95 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.